Kerb R[au] - Search Results

Year	Number of Results
1992	1
1993	1
1994	2
1996	3
1997	2
1998	2
1999	1
2000	2
2001	4
2002	6
2003	5
2004	8
2005	2
2006	3
2007	2
2008	2
2009	2
2011	2
2012	2
2013	2
2014	5
2015	1
2016	3
2017	1
2019	1
2020	2
2021	2
2022	1

1

Pharmacogenetics of antimalarial drugs: effect on metabolism and transport.

Kerb R, Fux R, Mörike K, Kremsner PG, Gil JP, Gleiter CH, Schwab M. Kerb R, et al. Lancet Infect Dis. 2009 Dec;9(12):760-74. doi: 10.1016/S1473-3099(09)70320-2. Lancet Infect Dis. 2009. PMID: 19926036 Review.

2

Heritability of metoprolol and torsemide pharmacokinetics.

Matthaei J, Brockmöller J, Tzvetkov MV, Sehrt D, Sachse-Seeboth C, Hjelmborg JB, Möller S, Halekoh U, Hofmann U, Schwab M, Kerb R. Matthaei J, et al. Among authors: kerb r. Clin Pharmacol Ther. 2015 Dec;98(6):611-21. doi: 10.1002/cpt.258. Epub 2015 Oct 19. Clin Pharmacol Ther. 2015. PMID: 26344676 Clinical Trial.

3

Data-driven personalization of a physiologically based pharmacokinetic model for caffeine: A systematic assessment.

Fendt R, Hofmann U, Schneider ARP, Schaeffeler E, Burghaus R, Yilmaz A, Blank LM, Kerb R, Lippert J, Schlender JF, Schwab M, Kuepfer L. Fendt R, et al. Among authors: kerb r. CPT Pharmacometrics Syst Pharmacol. 2021 Jul;10(7):782-793. doi: 10.1002/psp4.12646. Epub 2021 Jun 26. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 34053199 Free PMC article. Clinical Trial.

4

Implications of genetic polymorphisms in drug transporters for pharmacotherapy.

Kerb R. Kerb R. Cancer Lett. 2006 Mar 8;234(1):4-33. doi: 10.1016/j.canlet.2005.06.051. Epub 2006 Feb 28. Cancer Lett. 2006. PMID: 16504381 Review.

5

Stereoselective quantification of phase 1 and 2 metabolites of clomiphene in human plasma and urine.

Kröner P, Heinkele G, Kerb R, Igel S, Schwab M, Mürdter TE. Kröner P, et al. Among authors: kerb r. Talanta. 2021 Jan 1;221:121658. doi: 10.1016/j.talanta.2020.121658. Epub 2020 Sep 16. Talanta. 2021. PMID: 33076169

6

Inherited and Acquired Determinants of Hepatic CYP3A Activity in Humans.

Matthaei J, Bonat WH, Kerb R, Tzvetkov MV, Strube J, Brunke S, Sachse-Seeboth C, Sehrt D, Hofmann U, von Bornemann Hjelmborg J, Schwab M, Brockmöller J. Matthaei J, et al. Among authors: kerb r. Front Genet. 2020 Aug 21;11:944. doi: 10.3389/fgene.2020.00944. eCollection 2020. Front Genet. 2020. PMID: 32973880 Free PMC article.

7

ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2.

Kerb R, Hoffmeyer S, Brinkmann U. Kerb R, et al. Pharmacogenomics. 2001 Feb;2(1):51-64. doi: 10.1517/14622416.2.1.51. Pharmacogenomics. 2001. PMID: 11258197 Review.

8

Digoxin pharmacokinetics and MDR1 genetic polymorphisms.

Verstuyft C, Schwab M, Schaeffeler E, Kerb R, Brinkmann U, Jaillon P, Funck-Brentano C, Becquemont L. Verstuyft C, et al. Among authors: kerb r. Eur J Clin Pharmacol. 2003 Apr;58(12):809-12. doi: 10.1007/s00228-003-0567-5. Epub 2003 Mar 1. Eur J Clin Pharmacol. 2003. PMID: 12698307

9

Polymorphisms in xenobiotic conjugation and disease predisposition.

Brockmöller J, Cascorbi I, Kerb R, Sachse C, Roots I. Brockmöller J, et al. Among authors: kerb r. Toxicol Lett. 1998 Dec 28;102-103:173-83. doi: 10.1016/s0378-4274(98)00304-x. Toxicol Lett. 1998. PMID: 10022251 Review.

10

Translational learning from clinical studies predicts drug pharmacokinetics across patient populations.

Krauss M, Hofmann U, Schafmayer C, Igel S, Schlender J, Mueller C, Brosch M, von Schoenfels W, Erhart W, Schuppert A, Block M, Schaeffeler E, Boehmer G, Goerlitz L, Hoecker J, Lippert J, Kerb R, Hampe J, Kuepfer L, Schwab M. Krauss M, et al. Among authors: kerb r. NPJ Syst Biol Appl. 2017 Mar 28;3:11. doi: 10.1038/s41540-017-0012-5. eCollection 2017. NPJ Syst Biol Appl. 2017. PMID: 28649438 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results